Detalles de la búsqueda
1.
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.
Lancet
; 401(10383): 1159-1171, 2023 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871574
2.
Outcome of Biological Therapies and Small Molecules in Ulcerative Proctitis: A Belgian Multicenter Cohort Study.
Clin Gastroenterol Hepatol
; 22(1): 154-163.e3, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37442318
3.
RIGOROUS DONOR SELECTION FOR FMT IN ACTIVE ULCERATIVE COLITIS: KEY LESSONS FROM A RANDOMIZED CONTROLLED TRIAL HALTED FOR FUTILITY.
Clin Gastroenterol Hepatol
; 2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38788915
4.
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
Lancet
; 399(10340): 2031-2046, 2022 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644155
5.
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
Lancet
; 399(10340): 2015-2030, 2022 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644154
6.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 21(3): 771-788.e10, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36152897
7.
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
Gastroenterology
; 162(7): 1876-1890, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35122766
8.
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial.
Clin Gastroenterol Hepatol
; 20(9): 2074-2082, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34843987
9.
Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis.
Gastroenterology
; 158(3): 562-572.e12, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31470005
10.
Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease.
Clin Gastroenterol Hepatol
; 19(5): 947-954.e2, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32360982
11.
Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease.
Gastroenterology
; 159(1): 139-147, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32224129
12.
Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX.
Am J Gastroenterol
; 116(1): 134-141, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33177349
13.
Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial.
Gut
; 69(4): 658-664, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31285357
14.
Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia.
Clin Gastroenterol Hepatol
; 18(7): 1528-1536.e5, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31202983
15.
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease.
Clin Gastroenterol Hepatol
; 18(3): 637-646.e11, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31128336
16.
Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.
Gastroenterology
; 157(4): 997-1006.e6, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31175865
17.
Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease.
Clin Gastroenterol Hepatol
; 18(8): 1704-1718, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31881273
18.
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.
Gastroenterology
; 154(5): 1343-1351.e1, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29317275
19.
Analytical and diagnostic performance of Theradiag i-Tracker assays on IDS-iSYS for infliximab and adalimumab therapeutic drug monitoring.
Clin Chem Lab Med
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38379379
20.
Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial.
Gut
; 67(6): 1087-1094, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28698230